Definium Therapeutics, Inc.(DFTX)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
DFTX is scheduled to report on Nov 5, 2026, usually after the market closes. Analysts expect EPS of -$0.57.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±5.2%).
Did the stock rise after good news?
The next-day move after each of its last 4 EPS beats and 8 misses.
In plain words: it beat expectations 4 times, but the stock still fell 2 of those 4 times.
- Aug '26Missed▼ 0.0%
- May '26Missed▼ -5.0%
- Feb '26Missed▲ +0.9%
- Nov '25Missed▲ +3.2%
- Jul '25Missed▼ -7.2%
- May '25Beat▼ -2.0%
- Mar '25Missed▲ +3.6%
- Nov '24Beat▲ +12.9%
- Aug '24Beat▼ -3.8%
- May '24Missed▼ -5.1%
- Feb '24Missed▼ -3.8%
- Nov '23Beat▲ +14.4%
Clear beats and misses with a known reaction only. What counts as a beat
Why did DFTX fall after beating earnings?
5 of DFTX's last 12 reactions went against the EPS result. What stands out in each:
DFTX beat EPS estimates in 4 quarters, and the stock still closed lower the next day 2 times.
- May 8, 2025EPS beat +5.4%stock -2.0% next day
- It had risen 34.8% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 1.2% lower as soon as trading resumed.
- Aug 13, 2024EPS beat +12.1%stock -3.8% next day
- It opened 5.1% higher, but sellers took over and it closed -3.8%.
Rose despite an EPS miss (3 of 8)
- Feb 26, 2026EPS missed -2.0%stock +0.9% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
- Nov 6, 2025EPS missed -56.0%stock +3.2% next day
- It had already fallen 9.3% in the 20 trading sessions before the report, so weak results may have been expected.
- Mar 6, 2025EPS missed -46.4%stock +3.6% next day
- It had already fallen 21.9% in the 20 trading sessions before the report, so weak results may have been expected.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was DFTX's earnings move already priced in?
DFTX's move in the month before each of its last 12 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 12 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does DFTX hold its opening gap after earnings?
DFTX's opening move after each report and where it closed that day.
In 11 reports DFTX opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 11 times (36%), and fully reversed 4 times. Gaps up faded 1 of 3; gaps down recovered 3 of 8.
- May 7, 2026HeldOpened -1.5%, closed -5.0%
- Feb 26, 2026ReversedOpened -1.6%, closed +0.9%
- Nov 6, 2025ReversedOpened -3.4%, closed +3.2%
- Jul 31, 2025HeldOpened -6.4%, closed -7.2%
- May 8, 2025HeldOpened -1.2%, closed -2.0%
- Mar 6, 2025ReversedOpened -5.0%, closed +3.6%
- Nov 7, 2024HeldOpened +2.3%, closed +12.9%
- Aug 13, 2024ReversedOpened +5.1%, closed -3.8%
What the history says
- DFTX has missed EPS estimates in 5 straight quarters.
- It fell after 2 of its 4 EPS beats (50%): beating estimates has not been enough on its own.
DFTX earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | After close | -$0.55 | -$1.44 | -161.8% | 0.00% | -11.34% |
| May 7, 2026 | After close | -$0.49 | -$0.71 | -44.9% | -4.96% | -8.79% |
| Feb 26, 2026 | After close | -$0.49 | -$0.50 | -2.0% | +0.93% | +2.31% |
| Nov 6, 2025 | After close | -$0.50 | -$0.78 | -56.0% | +3.17% | +10.05% |
| Jul 31, 2025 | After close | -$0.36 | -$0.50 | -38.9% | -7.15% | +6.05% |
| May 8, 2025 | Before open | -$0.37 | -$0.35 | +5.4% | -1.97% | -2.12% |
| Mar 6, 2025 | Before open | -$0.28 | -$0.41 | -46.4% | +3.61% | -1.25% |
| Nov 7, 2024 | After close | -$0.26 | -$0.18 | +30.8% | +12.90% | +8.91% |
| Aug 13, 2024 | Before open | -$0.33 | -$0.29 | +12.1% | -3.80% | -6.28% |
| May 8, 2024 | After close | -$0.56 | -$1.14 | -103.6% | -5.10% | -12.07% |
| Feb 28, 2024 | Before open | -$0.48 | -$0.59 | -22.9% | -3.78% | +12.05% |
| Nov 2, 2023 | After close | -$0.67 | -$0.45 | +32.8% | +14.44% | +4.44% |
Consensus for the next report: EPS -$0.57, revenue $0.00.
DFTX Earnings FAQ
Answers computed from Definium Therapeutics, Inc.'s reported history
DFTX is scheduled to report on Nov 5, 2026, usually after the market closes. Analysts expect EPS of -$0.57.
Over the last 12 quarters with a usable EPS surprise, DFTX beat the consensus estimate 4 times (33%), missed 8 and landed in line 0. It has missed estimates in each of the last 5 counted quarters.
Across its last 12 quarters with a measured reaction, DFTX moved an average of ±5.2% in the first session after reporting. It closed higher 42% of the time; the largest gain was 14.4% and the largest drop -7.2%.
DFTX fell in the first session after 2 of its last 4 EPS beats (50%). A beat that was already priced in, or weaker guidance, can send a stock lower.
Across its last 12 quarters with price data, DFTX moved an average of +7.1% in the 20 trading sessions before reporting and was higher in 50% of them. After a run-up of 3% or more (5 quarters), it fell the next day 80% of the time, averaging -1.0%. After a drop of 3% or more (6 quarters), it rose the next day 50% of the time, averaging +2.1%. This describes past reports; it is not a forecast.
In 11 reports DFTX opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 11 times (36%), and fully reversed 4 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · DFTX: 12 reported quarters, latest Aug 6, 2026. Information only, not investment advice.
Looking for more on DFTX?
Price charts, forecast, fundamentals and risk pages for DFTX are not on Tickzen yet. You can run a full stock analysis now.
Run the DFTX Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun